US Device Guide

The Cardiac Interventions Today Europe Device Guide offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.

 

Current Supplement

SPONSORED BY ABBOTT

Managing the High Bleeding Risk PCI Patient

The latest thinking on DAPT guidelines and patient care.

 

News

 

UK NICE Issues Recommendations for Percutaneous Insertion of a Cerebral Protection Device During TAVI

June 18, 2019 -- The United Kingdom's National Institute for Health and Care Excellence (NICE) announced evidence-based recommendations on the percutaneous insertion of a …

Zoll Medical Acquires TherOx

June 18, 2019 -- Zoll Medical Corporation, an Asahi Kasei Group Company, announced it has acquired TherOx, Inc., a privately held company based in Irvine, California. TherOx i…

Orchestra BioMed Partners With Terumo to Develop and Commercialize the Virtue Sirolimus-Eluting Balloon

June 13, 2019 -- Orchestra BioMed, Inc. announced it has formed a global strategic partnership with Terumo Corporation for development and commercialization of Virtue sirolimu…

Analysis Demonstrates Benefits of Cardiac Dimensions' Carillon Mitral Contour System

June 13, 2019 -- Cardiac Dimensions, Inc. presented data showing that increased mitral valve tenting was associated with an improvement in regurgitant volume with use of the c…

Transseptal Solutions Announces First Clinical Use of TSP Crosser in the United States

June 12, 2019 -- Transseptal Solutions Ltd., an Israel-based developer of the TSP Crosser, which provides transeptal puncture and left atrial navigation in a single device, an…

Five-Year In-Hospital Outcomes After Percutaneous LAA Closure Reported From Nationwide German Study

June 10, 2019 -- Findings from a large study evaluating 5-year in-hospital trends and safety outcomes of left atrial appendage (LAA) closure in a German nationwide inpatient s…

Meril’s Myval Transcatheter Heart Valve Receives CE Mark Approval

June 10, 2019 -- Meril Life Sciences Pvt. Ltd. recently announced it has received European CE Mark approval for the company's Myval transcatheter heart valve (THV) system …

Findings Reported for FANTOM II Study of Reva Medical's Bioresorbable Scaffold

June 10, 2019 -- Twelve-month follow-up data from the FANTOM II study were published by Bernard Chevalier, MD, et al online in Circulation: Cardiovascular Interventions. …

Updated 1-Year BIOSOLVE-IV Data Presented for Biotronik's Magmaris Resorbable Scaffold

June 7, 2019 -- Biotronik announced that updated 12-month follow-up cohort results from the first 800 patients in the BIOSOLVE-IV registry were presented by the study's Pr…

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.